242 related articles for article (PubMed ID: 28412249)
21. T-LAK cell-originated protein kinase (TOPK) is a Novel Prognostic and Therapeutic Target in Chordoma.
Thanindratarn P; Dean DC; Nelson SD; Hornicek FJ; Duan Z
Cell Prolif; 2020 Oct; 53(10):e12901. PubMed ID: 32960500
[TBL] [Abstract][Full Text] [Related]
22. TOPK promotes lung cancer resistance to EGFR tyrosine kinase inhibitors by phosphorylating and activating c-Jun.
Li Y; Yang Z; Li W; Xu S; Wang T; Wang T; Niu M; Zhang S; Jia L; Li S
Oncotarget; 2016 Feb; 7(6):6748-64. PubMed ID: 26745678
[TBL] [Abstract][Full Text] [Related]
23. Baicalin suppresses lung cancer growth by targeting PDZ-binding kinase/T-LAK cell-originated protein kinase.
Diao X; Yang D; Chen Y; Liu W
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898980
[TBL] [Abstract][Full Text] [Related]
24. TOPK is highly expressed in circulating tumor cells, enabling metastasis of prostate cancer.
Sun H; Zhang L; Shi C; Hu P; Yan W; Wang Z; Duan Q; Lu F; Qin L; Lu T; Xiao J; Wang Y; Zhu F; Shao C
Oncotarget; 2015 May; 6(14):12392-404. PubMed ID: 25881543
[TBL] [Abstract][Full Text] [Related]
25. Mitotic kinase PBK/TOPK as a therapeutic target for adult T‑cell leukemia/lymphoma.
Ishikawa C; Senba M; Mori N
Int J Oncol; 2018 Aug; 53(2):801-814. PubMed ID: 29901068
[TBL] [Abstract][Full Text] [Related]
26. T-LAK Cell-Originated Protein Kinase (TOPK) as a Prognostic Factor and a Potential Therapeutic Target in Ovarian Cancer.
Ikeda Y; Park JH; Miyamoto T; Takamatsu N; Kato T; Iwasa A; Okabe S; Imai Y; Fujiwara K; Nakamura Y; Hasegawa K
Clin Cancer Res; 2016 Dec; 22(24):6110-6117. PubMed ID: 27334838
[TBL] [Abstract][Full Text] [Related]
27. Role of TOPK in lipopolysaccharide-induced breast cancer cell migration and invasion.
Seol MA; Park JH; Jeong JH; Lyu J; Han SY; Oh SM
Oncotarget; 2017 Jun; 8(25):40190-40203. PubMed ID: 28212583
[TBL] [Abstract][Full Text] [Related]
28. Cytoplasmic, nuclear, and total PBK/TOPK expression is associated with prognosis in colorectal cancer patients: A retrospective analysis based on immunohistochemistry stain of tissue microarrays.
Su TC; Chen CY; Tsai WC; Hsu HT; Yen HH; Sung WW; Chen CJ
PLoS One; 2018; 13(10):e0204866. PubMed ID: 30286126
[TBL] [Abstract][Full Text] [Related]
29. Oncogenic roles of TOPK and MELK, and effective growth suppression by small molecular inhibitors in kidney cancer cells.
Kato T; Inoue H; Imoto S; Tamada Y; Miyamoto T; Matsuo Y; Nakamura Y; Park JH
Oncotarget; 2016 Apr; 7(14):17652-64. PubMed ID: 26933922
[TBL] [Abstract][Full Text] [Related]
30. Lymphokine-activated killer T-cell-originated protein kinase phosphorylation of histone H2AX prevents arsenite-induced apoptosis in RPMI7951 melanoma cells.
Zykova TA; Zhu F; Lu C; Higgins L; Tatsumi Y; Abe Y; Bode AM; Dong Z
Clin Cancer Res; 2006 Dec; 12(23):6884-93. PubMed ID: 17145805
[TBL] [Abstract][Full Text] [Related]
31. Ischemic postconditioning relieves cerebral ischemia and reperfusion injury through activating T-LAK cell-originated protein kinase/protein kinase B pathway in rats.
Zhao H; Wang R; Tao Z; Gao L; Yan F; Gao Z; Liu X; Ji X; Luo Y
Stroke; 2014 Aug; 45(8):2417-24. PubMed ID: 25013016
[TBL] [Abstract][Full Text] [Related]
32. TOPK (T-LAK cell-originated protein kinase) inhibitor exhibits growth suppressive effect on small cell lung cancer.
Park JH; Inoue H; Kato T; Zewde M; Miyamoto T; Matsuo Y; Salgia R; Nakamura Y
Cancer Sci; 2017 Mar; 108(3):488-496. PubMed ID: 28075524
[TBL] [Abstract][Full Text] [Related]
33. Proton pump inhibitor ilaprazole suppresses cancer growth by targeting T-cell-originated protein kinase.
Zheng M; Luan S; Gao S; Cheng L; Hao B; Li J; Chen Y; Hou X; Chen L; Li H
Oncotarget; 2017 Jun; 8(24):39143-39153. PubMed ID: 28388576
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation and activation of the atypical kinase p53-related protein kinase (PRPK) by Akt/PKB.
Facchin S; Ruzzene M; Peggion C; Sartori G; Carignani G; Marin O; Brustolon F; Lopreiato R; Pinna LA
Cell Mol Life Sci; 2007 Oct; 64(19-20):2680-9. PubMed ID: 17712528
[TBL] [Abstract][Full Text] [Related]
35. CXCL8, overexpressed in colorectal cancer, enhances the resistance of colorectal cancer cells to anoikis.
Xiao YC; Yang ZB; Cheng XS; Fang XB; Shen T; Xia CF; Liu P; Qian HH; Sun B; Yin ZF; Li YF
Cancer Lett; 2015 May; 361(1):22-32. PubMed ID: 25687885
[TBL] [Abstract][Full Text] [Related]
36. T-lymphokine-activated killer cell-originated protein kinase functions as a positive regulator of c-Jun-NH2-kinase 1 signaling and H-Ras-induced cell transformation.
Oh SM; Zhu F; Cho YY; Lee KW; Kang BS; Kim HG; Zykova T; Bode AM; Dong Z
Cancer Res; 2007 Jun; 67(11):5186-94. PubMed ID: 17545598
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of nemo-like kinase is an independent prognostic factor in colorectal cancer.
Zhang W; He J; Du Y; Gao XH; Liu Y; Liu QZ; Chang WJ; Cao GW; Fu CG
World J Gastroenterol; 2015 Aug; 21(29):8836-47. PubMed ID: 26269673
[TBL] [Abstract][Full Text] [Related]
38. Acetylshikonin suppressed growth of colorectal tumour tissue and cells by inhibiting the intracellular kinase, T-lymphokine-activated killer cell-originated protein kinase.
Zhao R; Choi BY; Wei L; Fredimoses M; Yin F; Fu X; Chen H; Liu K; Kundu JK; Dong Z; Lee MH
Br J Pharmacol; 2020 May; 177(10):2303-2319. PubMed ID: 31985814
[TBL] [Abstract][Full Text] [Related]
39. Activation of TOPK by lipopolysaccharide promotes induction of inducible nitric oxide synthase through NF-κB activity in leukemia cells.
Park JH; Jeong YJ; Won HK; Choi SY; Park JH; Oh SM
Cell Signal; 2014 May; 26(5):849-56. PubMed ID: 24440499
[TBL] [Abstract][Full Text] [Related]
40. T-LAK cell-originated protein kinase presents a novel therapeutic target in FLT3-ITD mutated acute myeloid leukemia.
Alachkar H; Mutonga M; Malnassy G; Park JH; Fulton N; Woods A; Meng L; Kline J; Raca G; Odenike O; Takamatsu N; Miyamoto T; Matsuo Y; Stock W; Nakamura Y
Oncotarget; 2015 Oct; 6(32):33410-25. PubMed ID: 26450903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
